Clinical features of H1N1 2009 infection in critically ill immunocompromised patients.
Seasonal influenza virus has been described as an emerging and severe pathogen in immunocompromised hosts. Since the beginning of the 2009 influenza A novel H1N1 pandemic, several series have described the clinical course of the disease in various populations. We report the clinical course of H1N1 2009 infection in 10 immunocompromised patients. Half of the patients received long-term steroid therapy. Disease was characterized by a clinical picture similar to that of non-immunocompromised patients but with prolonged course and higher mortality.
Camous
Laurent
L
Medical Intensive Care Unit, Saint-Louis University Hospital, APHP, 1 Avenue Claude Vellefaux, Paris, France.
Lemiale
Virginie
V
Canet
Emmanuel
E
Max
Adeline
A
Schnell
David
D
Le Goff
Jerome
J
Rabbat
Antoine
A
Schlemmer
Benoit
B
Azoulay
Elie
E
D016638:Critical Illness; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000503:physiopathology*
Am J Transplant. 2002 Mar;2(3):287-91
12096793
N Engl J Med. 2009 Nov 12;361(20):1925-34
19815860
JAMA. 2009 Nov 4;302(17):1872-9
19822627
N Engl J Med. 2007 Dec 20;357(25):2601-14
18094380
JAMA. 2009 Nov 4;302(17):1896-902
19887665